Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla.
Level 5 - mechanism / opinion, no new human data
Narrative review of in vitro and molecular mechanistic bench studies
PubMed 21167691 · doi:10.1016/j.jdermsci.2010.10.015
What was done
This narrative review summarizes molecular research on androgen signaling in androgenetic alopecia (AGA), drawing from hormone binding assays, RT-PCR, and human dermal papilla cell/keratinocyte coculture models.
What was found
No numerical values or statistics are reported in the abstract. The abstract notes that expression of type II 5α-reductase, androgen receptor (AR), and AR coactivator Hic-5/ARA55 is higher in dermal papilla cells from AGA and beard sites than non-bald or other follicular sites, while type I 5α-reductase expression is relatively low. In cocultures of AR-overexpressing AGA dermal papilla cells and normal human keratinocytes, R1881 suppressed keratinocyte growth via androgen-inducible TGF-β1, with TGF-β2 and DKK-1 also identified as androgen-induced epithelial growth suppressors.
Why it matters
It outlines the cellular and paracrine mechanism by which androgen signaling in dermal papilla cells induces follicular miniaturization in AGA, identifying potential targets for therapy.
Limits
The abstract describes in vitro and bench mechanistic findings rather than clinical trial data. Sample sizes, quantitative measurements, variance, and in vivo clinical outcomes are not reported.
Cited by
- supports Androgenetic alopecia involves androgen-induced miniaturization of the hair follicle and a progressive shortening of the anagen growth phase.